SCHEMBL21251983

SCHEMBL21251983

COc1cccc(-c2cc3cnc(N)nc3c(NCCN3CCN(C)CC3)n2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 2/20 0.43
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 3/20 0.41
HIF1A Q16665 2/20 0.41
LMNA P02545 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PDPK1 O15530 1/20 0.40
CLK4 Q9HAZ1 2/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CD274 Q9NZQ7 1/20 0.38
USP2 O75604 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21251985 0.90 PGK1 (0.41) PGK1CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL20331085 0.81 PGK1 (0.45) PGK1PDPK1TLR9FGFR1
SCHEMBL20330753 0.81 PGK1 (0.46) PGK1TLR9FGFR1
SCHEMBL21252510 0.80 FGFR1 (0.49) PGK1CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL21240565 0.79 PGK1 (0.44) PGK1CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL30046372 0.79 PGK1 (0.44) PGK1CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL20332044 0.73 CYP1A2 (0.43) CYP1A2CYP3A4CYP2D6HIF1ALMNA
SCHEMBL20331055 0.73 FGFR1 (0.44) PGK1CYP1A2CYP3A4CYP2D6HIF1A
SCHEMBL20330743 0.73 SUV39H2 (0.44) CYP1A2CYP3A4CYP2D6HIF1ALMNA
SCHEMBL20331423 0.71 NOS3 (0.39) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 EP disclosed